Search
Conmed Corp
CNMDAdd to Watchlist
32.580USD
+0.500+1.56%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.01BMarket Cap
18.37P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Conmed Corp is 6.00, ranking 169 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 52.00, with a high of 55.00 and a low of 41.00.
Analyst Rating
Based on
6
analysts
Hold
Current Rating
39.500
Target Price
+23.01%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
65
Total
4
Median
6
Average
Company name
Ratings
Analysts
Conmed Corp
CNMD
6
Apple Inc
AAPL
49
Ge Vernova Inc
GEV
37
Tapestry Inc
TPR
24
Verisk Analytics Inc
VRSK
20
Avantor Inc
AVTR
19
1
2
3
...
13
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Conmed Corp's expected revenue for the next quarter?
Conmed Corp's expected revenue is 337.49M.
What is Conmed Corp's price target?
Analysts forecast that Conmed Corp's price target is USD 52.00, with the highest forecast at USD 55.00 and the lowest forecast at USD 41.00.
How have Conmed CorpCNMD's recent earnings per share performed?
The market expectation was USD 0.45, while Conmed CorpCNMD's earnings per share (EPS) for the previous quarter was USD 0.54. EPS for the next quarter is expected at USD 1.11.
What is the analyst rating for Conmed Corp?
Based on the ratings of Conmed Corp's stock from 6 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
